Compound Semaglutide
US$ 25.43
indications for glp 1 agonist The New Weight Management Meds GLP-1 receptor agonists and next-generation
Description
They are made by pharmaceutical manufacturers under strict oversight
Source: Cedars-sinai The presented results ( Source ) indicated that of the study participants, 37 people were on liraglutide and 18 on the placebo treatment
Scheme 7
For example, liraglutide was associated with a non-significant increased risk of HF relative to placebo [odds ratio ( OR ) = 4.85, 95% CI 0.7531.36] [89]
Ketema EB, Lopaschuk GD
doi:10.2337/dbi19-0023 159
